Is a complete AEON research report available?

No complete published report is available for AEON Biopharma, Inc. (AEON) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AEON Biopharma, Inc. (AEON)

NYSEAMERICAN: AEON · USD

$0.25

-0.01 (-3.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AEON analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.6M
Net income (ttm)	-60.1M
EPS (ttm)	-$3.15
Shares out	26.3M
Volume	284,978
Beta	0.61
Price target	$6.70	+2572.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -60.1M
EPS (ttm): -$3.15
Market cap: 6.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AEON indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001837607
Company name	AEON Biopharma, Inc.
Country	United States
Country code	US
Cusip	00791X209
Employees	8
Employees Change	3%
Employees Change Percent	60
Enterprise value	$3.1M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US00791X2099
Last refreshed	2026-07-25
Market cap	$6.6M
Market cap category	Nano-Cap
Price	$0.25
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	AEON
Website	https://www.aeonbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-894.05%
FCF yield	-179%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-60.1M
Net Income Growth Years	0%
Profit Per Employee	$-7.5M
ROA	-101.9
Roa5y	-295.1
ROCE	-629.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-70.15%
Cagr3y	-93.15%
Cagr5y	-79.53%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.6M
Cash	$6.2M
Current Assets	$6.6M
Current Liabilities	$6.7M
Debt	$2.6M
Equity	$-16.8M
Liabilities	$25.4M
Long Term Assets	$2M
Long Term Liabilities	$18.7M
Net Cash	$3.6M
Net Cash By Market Cap	$53.81
Tangible Book Value	$-16.8M
Tangible Book Value Per Share	$-0.66
WACC	5.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Net Working Capital	$-6M
Quick ratio	0.94
Working Capital	$-44,000

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,222.46%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-70.13%
200-day SMA	0.92
3Y total return	-99.97%
50-day SMA	0.64
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.96%
All Time High	1,236.2
All Time High Change	-99.98%
All Time High Date	2024-03-18
All Time Low	0.24
All Time Low Change	3.17%
All Time Low Date	2026-07-24
ATR	0.05
Beta	0.61
Beta1y	-0.48
Beta2y	1.33
Ch YTD	-77.21
High	0.26
High52	1.45
High52 Date	2026-02-23
High52ch	-82.71%
Low	0.24
Low52	0.24
Low52 Date	2026-07-24
Low52ch	3.17%
Ma50ch	-60.66%
Premarket Change Percent	0.77
Premarket Price	$0.26
Premarket Volume	15,457
Price vs 200-day SMA	-72.75%
RSI	17.61
RSI Monthly	29.85
RSI Weekly	29.09
Sharpe ratio	-0.7x
Sortino ratio	-0.91
Total Return	-1,222.46%
Tr YTD	-77.21
Tr1m	-63.78%
Tr1w	-14.99%
Tr3m	-75.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.33
Operating Income	$-18.3M
Price target	$6.7
Price Target Change	$2,573

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,934,398%
Float Percent	26.36%
Shares Insiders	8.81%
Shares Institutions	4.32%
Shares Out	26,307,211
Shares Qo Q	215.04%
Shares Yo Y	1,222.46%
Short Float	2.31%
Short Ratio	5.16
Short Shares	0.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.6M
Average Volume	2,659,298.3x
Bv Per Share	-0.66
Ch1m	-63.78
Ch1w	-14.99
Ch1y	-70.13
Ch3m	-75.89
Ch3y	-99.97
Ch5y	-99.96
Ch6m	-77.41
Change	-3.58%
Change From Open	-3.58
Close	0.26
Days Gap	0
Depreciation Amortization	78,000
Dollar Volume	71,444
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-12.3M
EBITDA	$-12.3M
EPS	$-3.15
F Score	2
FCF	$-12M
FCF EV Yield	-387.56x
FCF Per Share	$-0.46
Financing CF	7,832,000
Fiscal Year End	December
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-02-26
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.92
Ma150ch	-72.74%
Ma20	0.48
Ma20ch	-48.08%
Net CF	-4,203,000
Next Earnings Date	2026-08-11
Open	0.26
Optionable	No
Position In Range	45.29
Ppne	1,134,000
Pre Close	0.26
Price Date	2026-07-24
Relative Volume	0.11x
Share Based Comp	5,520,000
Tr6m	-77.41%
Us State	California
Volume	284,978

AEON Biopharma, Inc. (AEON)

Coverage state: Market snapshot only — no published research

Generate the first AEON analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AEON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AEON indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AEON

Frequently asked questions